Mechanisms of drug binding to voltage-gated sodium channels

Michael O'Leary, M. Chahine

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Voltage-gated sodium (Na+) channels are expressed in virtually all electrically excitable tissues and are essential for muscle contraction and the conduction of impulses within the peripheral and central nervous systems. Genetic disorders that disrupt the function of these channels produce an array of Na+ channelopathies resulting in neuronal impairment, chronic pain, neuromuscular pathologies, and cardiac arrhythmias. Because of their importance to the conduction of electrical signals, Na+ channels are the target of a wide variety of local anesthetic, antiarrhythmic, anticonvulsant, and antidepressant drugs. The voltage-gated family of Na+ channels is composed of α-subunits that encode for the voltage sensor domains and the Na+-selective permeation pore. In vivo, Na+ channel α-subunits are associated with one or more accessory β-subunits (β1–β4) that regulate gating properties, trafficking, and cell-surface expression of the channels. The permeation pore of Na+ channels is divided in two parts: the outer mouth of the pore is the site of the ion selectivity filter, while the inner cytoplasmic pore serves as the channel activation gate. The cytoplasmic lining of the permeation pore is formed by the S6 segments that include highly conserved aromatic amino acids important for drug binding. These residues are believed to undergo voltage-dependent conformational changes that alter drug binding as the channels cycle through the closed, open, and inactivated states. The purpose of this chapter is to broadly review the mechanisms of Na+ channel gating and the models used to describe drug binding and Na+ channel inhibition.

Original languageEnglish (US)
Title of host publicationHandbook of Experimental Pharmacology
PublisherSpringer New York LLC
Pages209-231
Number of pages23
DOIs
StatePublished - Jan 1 2018

Publication series

NameHandbook of Experimental Pharmacology
Volume246
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Fingerprint

Voltage-Gated Sodium Channels
Permeation
Electric potential
Channelopathies
Pharmaceutical Preparations
S 6
Aromatic Amino Acids
Inborn Genetic Diseases
Anti-Arrhythmia Agents
Peripheral Nervous System
Muscle Contraction
Local Anesthetics
Chronic Pain
Anticonvulsants
Antidepressive Agents
Mouth
Anesthetics
Cardiac Arrhythmias
Accessories
Neurology

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

O'Leary, M., & Chahine, M. (2018). Mechanisms of drug binding to voltage-gated sodium channels. In Handbook of Experimental Pharmacology (pp. 209-231). (Handbook of Experimental Pharmacology; Vol. 246). Springer New York LLC. https://doi.org/10.1007/164_2017_73
O'Leary, Michael ; Chahine, M. / Mechanisms of drug binding to voltage-gated sodium channels. Handbook of Experimental Pharmacology. Springer New York LLC, 2018. pp. 209-231 (Handbook of Experimental Pharmacology).
@inbook{6157333e808142fb973a3ed675ccf84e,
title = "Mechanisms of drug binding to voltage-gated sodium channels",
abstract = "Voltage-gated sodium (Na+) channels are expressed in virtually all electrically excitable tissues and are essential for muscle contraction and the conduction of impulses within the peripheral and central nervous systems. Genetic disorders that disrupt the function of these channels produce an array of Na+ channelopathies resulting in neuronal impairment, chronic pain, neuromuscular pathologies, and cardiac arrhythmias. Because of their importance to the conduction of electrical signals, Na+ channels are the target of a wide variety of local anesthetic, antiarrhythmic, anticonvulsant, and antidepressant drugs. The voltage-gated family of Na+ channels is composed of α-subunits that encode for the voltage sensor domains and the Na+-selective permeation pore. In vivo, Na+ channel α-subunits are associated with one or more accessory β-subunits (β1–β4) that regulate gating properties, trafficking, and cell-surface expression of the channels. The permeation pore of Na+ channels is divided in two parts: the outer mouth of the pore is the site of the ion selectivity filter, while the inner cytoplasmic pore serves as the channel activation gate. The cytoplasmic lining of the permeation pore is formed by the S6 segments that include highly conserved aromatic amino acids important for drug binding. These residues are believed to undergo voltage-dependent conformational changes that alter drug binding as the channels cycle through the closed, open, and inactivated states. The purpose of this chapter is to broadly review the mechanisms of Na+ channel gating and the models used to describe drug binding and Na+ channel inhibition.",
author = "Michael O'Leary and M. Chahine",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/164_2017_73",
language = "English (US)",
series = "Handbook of Experimental Pharmacology",
publisher = "Springer New York LLC",
pages = "209--231",
booktitle = "Handbook of Experimental Pharmacology",

}

O'Leary, M & Chahine, M 2018, Mechanisms of drug binding to voltage-gated sodium channels. in Handbook of Experimental Pharmacology. Handbook of Experimental Pharmacology, vol. 246, Springer New York LLC, pp. 209-231. https://doi.org/10.1007/164_2017_73

Mechanisms of drug binding to voltage-gated sodium channels. / O'Leary, Michael; Chahine, M.

Handbook of Experimental Pharmacology. Springer New York LLC, 2018. p. 209-231 (Handbook of Experimental Pharmacology; Vol. 246).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Mechanisms of drug binding to voltage-gated sodium channels

AU - O'Leary, Michael

AU - Chahine, M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Voltage-gated sodium (Na+) channels are expressed in virtually all electrically excitable tissues and are essential for muscle contraction and the conduction of impulses within the peripheral and central nervous systems. Genetic disorders that disrupt the function of these channels produce an array of Na+ channelopathies resulting in neuronal impairment, chronic pain, neuromuscular pathologies, and cardiac arrhythmias. Because of their importance to the conduction of electrical signals, Na+ channels are the target of a wide variety of local anesthetic, antiarrhythmic, anticonvulsant, and antidepressant drugs. The voltage-gated family of Na+ channels is composed of α-subunits that encode for the voltage sensor domains and the Na+-selective permeation pore. In vivo, Na+ channel α-subunits are associated with one or more accessory β-subunits (β1–β4) that regulate gating properties, trafficking, and cell-surface expression of the channels. The permeation pore of Na+ channels is divided in two parts: the outer mouth of the pore is the site of the ion selectivity filter, while the inner cytoplasmic pore serves as the channel activation gate. The cytoplasmic lining of the permeation pore is formed by the S6 segments that include highly conserved aromatic amino acids important for drug binding. These residues are believed to undergo voltage-dependent conformational changes that alter drug binding as the channels cycle through the closed, open, and inactivated states. The purpose of this chapter is to broadly review the mechanisms of Na+ channel gating and the models used to describe drug binding and Na+ channel inhibition.

AB - Voltage-gated sodium (Na+) channels are expressed in virtually all electrically excitable tissues and are essential for muscle contraction and the conduction of impulses within the peripheral and central nervous systems. Genetic disorders that disrupt the function of these channels produce an array of Na+ channelopathies resulting in neuronal impairment, chronic pain, neuromuscular pathologies, and cardiac arrhythmias. Because of their importance to the conduction of electrical signals, Na+ channels are the target of a wide variety of local anesthetic, antiarrhythmic, anticonvulsant, and antidepressant drugs. The voltage-gated family of Na+ channels is composed of α-subunits that encode for the voltage sensor domains and the Na+-selective permeation pore. In vivo, Na+ channel α-subunits are associated with one or more accessory β-subunits (β1–β4) that regulate gating properties, trafficking, and cell-surface expression of the channels. The permeation pore of Na+ channels is divided in two parts: the outer mouth of the pore is the site of the ion selectivity filter, while the inner cytoplasmic pore serves as the channel activation gate. The cytoplasmic lining of the permeation pore is formed by the S6 segments that include highly conserved aromatic amino acids important for drug binding. These residues are believed to undergo voltage-dependent conformational changes that alter drug binding as the channels cycle through the closed, open, and inactivated states. The purpose of this chapter is to broadly review the mechanisms of Na+ channel gating and the models used to describe drug binding and Na+ channel inhibition.

UR - http://www.scopus.com/inward/record.url?scp=85047243392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047243392&partnerID=8YFLogxK

U2 - 10.1007/164_2017_73

DO - 10.1007/164_2017_73

M3 - Chapter

C2 - 29138928

AN - SCOPUS:85047243392

T3 - Handbook of Experimental Pharmacology

SP - 209

EP - 231

BT - Handbook of Experimental Pharmacology

PB - Springer New York LLC

ER -

O'Leary M, Chahine M. Mechanisms of drug binding to voltage-gated sodium channels. In Handbook of Experimental Pharmacology. Springer New York LLC. 2018. p. 209-231. (Handbook of Experimental Pharmacology). https://doi.org/10.1007/164_2017_73